Literature DB >> 7389104

Fatty acid composition of erythrocyte phospholipids from patients with cystic fibrosis.

V S Hubbard, G D Dunn.   

Abstract

The phospholipid fatty acid composition of erythrocytes from patients with cystic fibrosis with pancreatic insufficiency, patients with cystic fibrosis with normal pancreatic enzyme function, and normal subjects was determined. Increased percentages of palmitoleic acid and total eicosatrienoic acid and a decreased percentage of linoleic acid were observed only in the cystic fibrosis patients with pancreatic insufficiency.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7389104     DOI： 10.1016/0009-8981(80)90441-6

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN： 0009-8981            Impact factor:   3.786


  10 in total

Review 1.  Laboratory measurement of nutrition in cystic fibrosis.

Authors:  J Kelleher
Journal:  J R Soc Med       Date:  1987       Impact factor: 5.344

2.  What is the association of essential fatty acid status with cystic fibrosis?

Authors:  V S Hubbard
Journal:  Eur J Pediatr       Date:  1983-12       Impact factor: 3.183

3.  Elevated plasma levels of F2 alpha isoprostane in cystic fibrosis.

Authors:  C E Collins; P Quaggiotto; L Wood; E V O'Loughlin; R L Henry; M L Garg
Journal:  Lipids       Date:  1999-06       Impact factor: 1.880

4.  Increased elongase 6 and Δ9-desaturase activity are associated with n-7 and n-9 fatty acid changes in cystic fibrosis.

Authors:  Kelly F Thomsen; Michael Laposata; Sarah W Njoroge; Obi C Umunakwe; Waddah Katrangi; Adam C Seegmiller
Journal:  Lipids       Date:  2011-05-05       Impact factor: 1.880

5.  Absorption of safflower oil and structured lipid preparations in patients with cystic fibrosis.

Authors:  V S Hubbard; M C McKenna
Journal:  Lipids       Date:  1987-06       Impact factor: 1.880

6.  Inflammatory pleuropulmonary fibrosis in essential fatty acid deficient rats and the lack of response to methysergide.

Authors:  M J Parnham; C E Essed; A Montfoort; E L Spierings
Journal:  Agents Actions       Date:  1984-02

7.  Abnormal fatty acid pattern of the plasma cholesterol ester fraction in cystic fibrosis patients with and without pancreatic insufficiency.

Authors:  V Rogiers; A Vercruysse; I Dab; D Baran
Journal:  Eur J Pediatr       Date:  1983-10       Impact factor: 3.183

8.  Plasma and lipoprotein fatty acid composition in glycogen storage disease type I.

Authors:  E Levy; J Letarte; G Lepage; L Thibault; C C Roy
Journal:  Lipids       Date:  1987-06       Impact factor: 1.880

9.  Application of a new test for vitamin E deficiency to cystic fibrosis.

Authors:  H A Cynamon; J N Isenberg
Journal:  Eur J Pediatr       Date:  1987-09       Impact factor: 3.183

Review 10.  Abnormal unsaturated fatty acid metabolism in cystic fibrosis: biochemical mechanisms and clinical implications.

Authors:  Adam C Seegmiller
Journal:  Int J Mol Sci       Date:  2014-09-11       Impact factor: 5.923
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.